Complicated lichenoid drug eruption

Australasian Journal of Dermatology

Volumn 46, Issue 1, 2005, Pages 21-24

  Armour, Katherine ^a   Lowe, Patricia ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Granulocyte colony stimulating factor; Hepatitis C; Interferon; Propranolol; Ribavirin

Indexed keywords

PEGINTERFERON ALPHA2A; PREDNISONE; PROPRANOLOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN; TACROLIMUS;

ARTICLE; CHEEK MUCOSA; DEPRESSION; DRUG ERUPTION; ECZEMA; HEPATITIS C; HUMAN; IRRITABILITY; LETHARGY; LEUKOPENIA; LICHENOID ERUPTION; MALE; PENIS GLANS; PORTAL HYPERTENSION; PRURITUS; PSORIASIS; SIDE EFFECT;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LICHENOID ERUPTIONS; MALE; MIDDLE AGED; ORAL ULCER; PROPRANOLOL; RIBAVIRIN; SCROTUM; SEVERITY OF ILLNESS INDEX; SKIN ULCER;

EID: 14144249459     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.00131.x     Document Type: Article

References (17)

1. Daoud MS, Pittelkow MR. Lichen planus. In: Freedberg IM, Eisen AZ, Wolff R, Austen KF, Goldsmith LA, Ratz SI (eds). Fitzpatrick's Dermatology in General Medicine, Vol. 1, 6th edn. New York: McGraw-Hill, 2003; 463-77.
2. Chutaputti A. Adverse effects and other safety aspects of hepatitis C antivirals. J. Gastroenterol. Hepatol 2000; 15: E156-63.
3. Dalekos GN, Hatzis J, Tsianos EV. Dermatologic disease during interferon-alpha therapy for chronic viral hepatitis. Ann. Intern. Med. 1998; 128: 409-10.
4. Pinto JM, Marques MS, Correia TE. Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis. J. Eur. Acad. Dermatol. Venereol 2003; 17: 193-5.
5. Sookoian S, Neglia V, Castano G, Frider B, Kien MC, Chohuela E. High prevalence of cutaneous reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch. Dermatol. 1999; 135: 1000-1.
6. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou J-J. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: A series of 20 patients. Br. J. Dermatol. 2002; 147: 1142-6.
7. Nagao Y, Sata M, Suzuki H, Kameyama T, Ueno T. Histological improvement of oral lichen planus in patients with chronic hepatitis C treated with interferon. Gastroenterology 1999; 117: 283-4.
8. Lapidoth M, Arber N, Ben-Amitai D, Hagler J. Successful interferon treatment for lichen planus associated with chronic active hepatitis due to hepatitis C infection. Acta Derm. Venereol. 1997; 77: 171-2.
9. Massa MC, Jason SM, Gradini R, Welykyj S. Lichenoid drug eruption secondary to propranolol. Cutis 1991; 48: 41-3.
10. Hawk JL. Lichenoid drug eruption induced by propranolol. Clin. Exp. Dermatol. 1980; 5: 93-6.
11. Cochran REI, Thomson JT, McQueen A, Beevers DG. Skin reactions associated with propranolol. Arch. Dermatol. 1976; 112: 1173-4.
12. Viallard AM, Lavenue A, Balme B, Pincemaille B, Raudrant D, Thomas L. Lichenoid cutaneous drug reaction at injection sites of granulocyte colony-stimulating factor (Filgrastim). Dermatology 1999; 198: 301-3.
13. Swaber MJ, Zlotogoski A. Dermatologic manifestations of hepatitis C infection. Int. J. Dermatol. 1997; 36: 251-4.
14. Sanchez-Perez J, De Castro M, Buezo GF, Fernandez-Herrera J, Borque MJ, Garcia-Diez A. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C infection. Br. J. Dermatol. 1996; 134: 715-19.
15. Prendiville J, Thiessen P, Mallory S. Neutrophilic dermatoses in two children with idiopathic neutropenia: association with granulocyte colony-stimulating factor (G-CSF) therapy. Pediatr. Dermatol. 2001; 18: 417-21.
16. Paul C, Giachetti S, Pinquier L, Flaguel B, Dubertret L, Calvo F. Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteers. Arch. Dermatol. 1998; 134: 111-12.
17. Propranolol. Micromedex. Available from URL: http://micromedex.hcn.net.au (Accessed 20 October 2003).